OSR

ADAMA Launches New Multi-Crop, Broad Spectrum Fungicide Maxentis® for Improved Disease Control and Increased Yield

Retrieved on: 
Tuesday, April 9, 2024
Wheat, Farmer, Disease, Canker, OSR, Rape, TEL, SDHI, Agriculture

In high potential wheat areas Maxentis® can be used as a T1 application in a spray program with other fungicides, or as a standalone T1 or T2 broad spectrum product in lower-potential areas.

Key Points: 
  • In high potential wheat areas Maxentis® can be used as a T1 application in a spray program with other fungicides, or as a standalone T1 or T2 broad spectrum product in lower-potential areas.
  • This means that fungal diseases are controlled across multiple growth stages of the disease, resulting in greater efficacy and healthier crops.
  • Maxentis® delivers dependable control of the most important diseases in wheat, barley, and OSR, in a single convenient product that's ready to go when you are.
  • Maxentis® is part of ADAMA's new European cereal fungicide portfolio, which it began rolling out in 2023.

KNAPP Launches “Zero Touch” in North American Market

Retrieved on: 
Tuesday, March 12, 2024
Technology, Transport, Software, Electronic Design Automation, Robotics, Data Management, Logistics, Supply Chain Management, Retail, Artificial Intelligence, RFID, Next, Garmin, Pick, Running, AI, ASOS, WCS, OSR, SKU, Robot, REI, Marks & Spencer, WMS, Warehouse

KNAPP, a global leader providing intelligent intralogistics solutions today announced the release of Mission: Zero Touch to the North American market.

Key Points: 
  • KNAPP, a global leader providing intelligent intralogistics solutions today announced the release of Mission: Zero Touch to the North American market.
  • Achieving Mission: Zero Touch utilizes a variety of technologies, including KNAPP OSR Shuttles, PiE Robots, OSR Shuttle Evo Frozen and the latest product development, intelligent pocket sortation.
  • The glue for the application is a layer of software technologies delivered by KNAPP including WMS, WCS and AI enabled technologies across the spectrum of KNAPP products.
  • Combined with Pick-it-Easy Robot, a fully automatic picking robot, AutoPocket offers intelligent zero-touch handling for high performance applications.

KNAPP Launches Shuttle for Freezer Applications

Retrieved on: 
Tuesday, March 12, 2024
Software, Mobile, Wireless, Supply Chain Management, Networks, Other Retail, Data Management, Technology, Other Manufacturing, Retail, Transport, Other Technology, Logistics, Manufacturing, Temperature, Manual, Automation, Environment, ASRS, COVID-19, Travel, Sale, Shufersal, OSR, CSO, WMS, Warehouse

KNAPP, a global leader of intelligent intralogistics solutions, today announced that they will commence sale and implementation of their industry leading OSR shuttle technology for cold chain applications and projects.

Key Points: 
  • KNAPP, a global leader of intelligent intralogistics solutions, today announced that they will commence sale and implementation of their industry leading OSR shuttle technology for cold chain applications and projects.
  • As medical breakthroughs have increased, including Covid 19 and other vaccinations, so has the need for innovative cold chain automation solutions.
  • Another factor that contributes to the prospective success of KNAPP is the desire on the part of cold chain operators to keep workers out of the harsh freezer environment which is both costly and hard to staff.
  • KNAPP mixed load palletizing technology includes a unique set of attributes that are conducive to the needs of many cold chain operators.

Emerging Markets Report: A Deep Dive into Artificial Intelligence

Retrieved on: 
Thursday, June 1, 2023
Civil service commission, Synthetic media, ChatGPT, OSR, Alyson Stoner, Urban Air Mobility, Brain, Collection, Nature, Artificial intelligence, City, AI, European Commission, Automation, Customer service, Medical device, Nursing, EU

ORLANDO, Fla., June 01, 2023 (GLOBE NEWSWIRE) -- Earlier this week, we had the great honor of introducing you to VERSES AI Inc. (VERS.NE) (OTCQX:VRSSF), a cognitive computing company specializing in next-generation Artificial Intelligence. We touched on VERSES’s ‘human’ thinking AI model, how it differs from ChatGPT and the possibility that the Company’s technology is changing the very Art of Artificial Intelligence.

Key Points: 
  • We touched on VERSES’s ‘human’ thinking AI model, how it differs from ChatGPT and the possibility that the Company’s technology is changing the very Art of Artificial Intelligence.
  • Today, we would like to provide a deep dive into the phenomenon that seems to be taking over the world and what accomplishments VERSES has achieved to move up in the industry.
  • Artificial Intelligence, or AI, is a concept that can be hard to define because it does not come down to just one thing.
  • It is a collection of things, or technologies, that are brought together to basically replicate the human mind.

VERSES Expands Autonomous Drone Governance Infrastructure powered by KOSM to Milan, Italy

Retrieved on: 
Tuesday, May 16, 2023
Well, Maintenance, Civil service commission, General Data Protection Regulation, OSR, Urban Air Mobility, Privacy, Pharmacist, Patient, Laboratory, San Raffaele Hospital, Artificial intelligence, GDPR, City, AI, UAM, Telemedicine and Advanced Technology Research Center (United States Army), Software architecture, CBOE, European Commission, Medical device, Health, European

Utilizing VERSES’ real time mobility portal, powered by the company’s operating system for AI, KOSM, hospital staff were able to autonomously deliver medicines across campus, and monitor against trespassers on premises.

Key Points: 
  • Utilizing VERSES’ real time mobility portal, powered by the company’s operating system for AI, KOSM, hospital staff were able to autonomously deliver medicines across campus, and monitor against trespassers on premises.
  • San Raffaele Hospital showcased how drone services can be safely integrated in a hospital environment to conduct autonomous operations for delivering valuable resources and maintaining physical safety on premises.
  • “This was an exciting project for VERSES, and we appreciate the collaboration with OSR on deploying autonomous drone management for the hospital,” said Gabriel René, Founder and CEO of VERSES.
  • The 4th and 5th demonstrations in Oulu (Finland) and Tartu (Estonia) are anticipated to take place in Q3 2023.

Genenta Announces Extension of License Agreement with Ospedale San Raffaele to All Solid Tumor Indications

Retrieved on: 
Monday, April 3, 2023
OSR, Research, San Raffaele Hospital, Stem cell, Glioblastoma, Pharmaceutical industry

"We are pleased to reaffirm Genenta's collaboration with OSR by expanding our license agreement and providing our platform access to all solid tumor indications," said Pierluigi Paracchi, Chief Executive Officer of Genenta.

Key Points: 
  • "We are pleased to reaffirm Genenta's collaboration with OSR by expanding our license agreement and providing our platform access to all solid tumor indications," said Pierluigi Paracchi, Chief Executive Officer of Genenta.
  • "This agreement will strengthen the breadth of our IP position and confirm options for combination treatments and other potential payloads.
  • Promising preliminary clinical data generated in the ongoing study of our first solid tumor indication in glioblastoma supports our decision to expand the license to cover all solid tumors and primes our ability to impact other hard-to-treat cancer types."
  • The amended and restated license agreement reinforces Genenta's long-term strategic relationship with OSR, who contributes unique and valuable expertise to the development of cell-based therapies.

ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services

Retrieved on: 
Tuesday, August 23, 2022
Odyssey, RuneScape, Partnership, Patient, BLA, NDA, Technology, CEO, Safety, Regulation, Solution, R, Publishing, CMC, PPG, Pharmacovigilance, Promotion, Leadership, Regulatory affairs, Compliance, Biotechnology, History, Fujitsu Technology Solutions, Marketing, Advertising, OSR, Industry, Health, Review, Acquisition, Medical device, Risk management, Pharmaceutical industry

CHICAGO, Aug. 23, 2022 /PRNewswire-PRWeb/ -- ProPharma Group's acquisition of OSR is an advancement in its dynamic growth strategy, focused on combining best-in-class services and solutions to the life sciences industry. OSR strengthens ProPharma Group's portfolio of services with their stature as a market leader in support services that span from pre-launch, launch and post-approval across the entire product lifecycle.

Key Points: 
  • ProPharma Group (PPG), the leading global provider of regulatory, clinical, quality and compliance, medical information, and pharmacovigilance services and solutions for the life sciences industry, has announced the acquisition of OneSource Regulatory (OSR) and OneSource Regulatory Technology (OSR-T).
  • We are excited to see what the future holds for OneSource Regulatory and ProPharma Group."
  • ProPharma Group is the global, independent, single-source provider of regulatory, clinical, and compliance services serving pharmaceutical, biotechnology, and medical device companies.
  • Established in 2015, OneSource Regulatory and OneSource Regulatory Technology, headquartered in McKinney, Texas,, provides pre- and post-approval regulatory, medical and marketing operations services across the product development and commercial lifecycle as well as innovative technology solutions.

Outlook on the Super-Resolution Microscopes Global Market to 2028 - Increased Clarity and Precision is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 18, 2022
Technology, Science, Hardware, Research, OSR, Live cell imaging, Quantum, 3D, Technology, STED, Learning, Light, List of life sciences, Cell, SRM, Acquisition, Bacteria, Neurology, Virology, SNR, SML, TIRF, CAGR, Global, Protein, HIV, Immune system, Microscope, Nanotechnology

The Global Super-resolution Microscopes Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 9.9% CAGR during the forecast period.

Key Points: 
  • The Global Super-resolution Microscopes Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 9.9% CAGR during the forecast period.
  • A super-resolution microscope is a form of light microscope that captures an object's picture at a higher resolution than the diffraction limit allows.
  • Super-resolution microscopes offer unrivaled detail and insight into the molecular world.
  • Ultrafast imaging rates enable super-resolution features in 3D samples as well as live-cell experiments to be revealed quickly with super-resolution microscopes.

The tech company OSR Enterprises AG, led by founder and CEO Orit Shifman, to double its R&D workforce

Retrieved on: 
Wednesday, August 17, 2022
Brain, Technology, OSR, Software, Workforce, 2600-series (CTA), Industry, CEO, Jaguar Land Rover, AI, Management, Medical device

ROTKREUZ, Switzerland, Aug. 17, 2022 /PRNewswire/ -- OSR Enterprises AG, established in 2011 by the entrepreneur Orit Shifman, is recruiting hardware and software engineers, developers, and AI specialists for its advanced R&D centers worldwide, effectively doubling its R&D workforce.

Key Points: 
  • Since 2011 OSR has been laying new technological foundations for the automotive industry by replacing the traditional distributed vehicular architecture with a centralized one.
  • OSR's centralized architecture is based on a single AI-powered central-brain, the EVOLVER, which enables better, safer, and much smarter cars.
  • The 4th generation was introduced two years later, as part of the cooperation between OSR Enterprises AG and Jaguar Land-Rover.
  • ", explains Orit Shifman, CEO and founder of OSR Enterprises AG .

Thoracic Aortic Stent Grafts Pipeline Insights and Competitive Landscape Report 2022: Brand Positioning of Leading Companies, Application, Industry Collaborations - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 31, 2022
Health, Cardiology, Nexus, NEXUS, Heart, Sale, EVAR, Smoking, Aortic dissection, Cook Group, Bentall procedure, Growth, Competitive landscape, Patient, CVD, Vein, Medtronic, Time-invariant system, CT, Incidence, Northwell Health, Safety, Anatomy, Acquisition, Degenerative disease, Physician, Aortic arch, News, OSR, Interrupted aortic arch, Aortic aneurysm, FDA, Aneurysm, Blood, PMA, Endovascular aneurysm repair, Oil, Medical device

The "Thoracic Aortic Stent Grafts-Pipeline Insight and Competitive Landscape, 2022" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Thoracic Aortic Stent Grafts-Pipeline Insight and Competitive Landscape, 2022" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This "Thoracic Aortic Stent Grafts-Pipeline Insight and 2022" report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Thoracic Aortic Stent Grafts pipeline landscape.
  • This report provides a detailed study of the emerging Thoracic Aortic Stent Grafts devices along with competitive landscape to help better understand the emerging Thoracic Aortic Stent Grafts devices.
  • Thoracic Aortic Stent Grafts can be divided based on Treatment Types - Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR), Abdominal Aortic Aneurysm Repair, Thoracic Aortic Aneurysm Repair & Thoracic Endovascular Aneurysm Repair.